印度生物技术产业成功的关键因素分析  

The Analysis of the Key Factors About Achievement in Indian Biotechnology Industry

作　　者：高云华[1] 吴曙霞[1] 刁天喜[1] 庞乐君[1] 

机构地区：[1]军事医学科学院卫生勤务与医学情报研究所,北京100850

出　　处：《中国药事》2008年第2期161-164,共4页Chinese Pharmaceutical Affairs

基　　金：国家863计划项目(2006AA02Z316)

摘　　要：印度生物技术产业2005年注册收入达到近11亿美元,2006年达到15亿美元,近年印度在该领域的发展取得了突飞猛进的成绩,联合国已把印度作为发展中国家生物工程技术培训中心,欧美等发达国家则将其作为生物技术试验基地,不少跨国公司和医药巨头也纷纷拥入。概要描述了印度生物技术产业的概况,对印度生物技术产业近年来高速发展的成功因素进行了重点阐述,并指出了其发展中存在的问题。The registered revenue of Indian biotechnology industry reached nearly 1.5 billion dollars in 2006, up from 1.1 billion dollars in 2005. In recent years, India had made rapid progress in this field. The United Nations had designated India as a biological engineering technology training center for developing countries and a test base of Europe, the United States and other developed countries, while many multinational companies and pharmaceutical giants had also poured into India. This article briefly describes the Indian biotechnology industry profile and focuses on the success factors of rapid development, and finally indicates the existing problems while developing.

关 键 词：生物技术 产业 印度 

分 类 号：F062.4[经济管理—政治经济学]